Brain tumor drug wafers under the microscope: Real-World results revealed
Knowledge-focused
Completed
This study followed 272 adults with brain tumors who received Gliadel wafers (chemotherapy implants) as part of their normal treatment. Researchers tracked how long patients lived, how long until the tumor came back, and any serious side effects. The goal was to see how well the …
Sponsor: Arbor Pharmaceuticals, Inc. • Aim: Knowledge-focused
Last updated May 17, 2026 10:26 UTC